News
US drug companies battle over dyspepsia drugs
BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7009.828a (Published 30 September 1995) Cite this as: BMJ 1995;311:828- FRED B CHARATAN, freelance journalist
- Florida
The recent decision by the US Food and Drug Administration to approve several drugs for dyspepsia for sale over the counter has led to increased rivalry among drug manufacturers. Three products have now been approved for non-prescription use, and a fourth goes before the administration later this month.
Remedies for dyspepsia rank only just behind analgesics and preparations for use in common colds on the nation's pharmacy shelves. The first drug of its class to receive approval …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.